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Background: Following AIM2 inflammasome activation, EB1 is required for speck formation.
Results: EB1 regulates AIM2 inflammasome-induced IL-1 secretion via autophagic shedding after speck formation; further-
more, AMPK may regulate this via EB1.
Conclusion: AIM2 inflammasome-induced IL-1 secretion depends on autophagy-based secretory trafficking through EB1
regulation.
Significance:We identify a novel role for EB1 in the non-classical secretion of IL-1 by AIM2 inflammasome complexes.
Inflammasomes are multi-protein complexes that regulate
chronic inflammation-associated diseases by inducing interleu-
kin-1  (IL-1) secretion. Numerous components involved in
inflammasome activation have been identified, but the mecha-
nisms of inflammasome-mediated IL-1 secretion have not yet
been fully explored. Here, we demonstrate that end-binding
protein 1 (EB1),which is required for activationofAIM2 inflam-
masome complex, links the AIM2 inflammasome to autophagy-
dependent secretion. Imaging studies revealed that AIM2 inflam-
masomes colocalize with microtubule organizing centers and
autophagosomes. Biochemical analyses showed that poly(dA-dT)-
activated AIM2 inflammasomes induce autophagy and IL-1
secretion in anLC3-dependent fashion. Furthermore, depletion of
EB1 decreases autophagic shedding and intracellular trafficking.
Finally, we found that the 5-AMP activated protein kinase may
regulate this EB1-mediated autophagy-based inflammasome-in-
duced secretion of IL-1. These findings reveal a novel EB1-medi-
ated pathway for the secretion of IL-1.
Inflammasomes are intracellular protein complexes that
sense various pathogenic infections and cause inflammation by
inducing the secretion of interleukin 1  (IL-1) or interleukin
18 (IL-18) (1). Numerous studies have revealed that inflam-
masomes participate in various diseases (e.g. cancers, diabetes,
and Alzheimer disease) by regulating IL-1 secretion (2–4).
Inflammasomes are multi-protein complexes that comprise
receptors (e.g.NLPR3, AIM2, and NLRC4), an adaptive protein
ASC, and procaspase 1. The receptors activate procaspase 1 via
ASC (apoptosis-associated speck-like protein containing a
CARD)-dependent or -independent mechanisms, and the acti-
vated caspase 1 subsequently triggers IL-1 secretion (1). The
typical mechanism of IL-1 secretion requires two signals: (i)
transcriptional regulation of pro-IL-1 and (ii) inflammasome
activation-mediated secretion of IL-1. An activated inflam-
masome is seen as a single perinuclear complex in cells; this is
called a “speck-like particle” (5). Interestingly, inflammasomes
not only sense pathogenic infections, they also detect cellular
damage signals (e.g. reactive oxygen species production and
ATP release) (6, 7). Such innate immune responses are seen in
immune cells and other cell types (2, 8), indicating that inflam-
masome activation is a topic of general interest. However, the
underlying biological processes are not yet fully understood.
We previously reported that the NLRP3, AIM2, and RIG-I
inflammasomes are activated in nasopharyngeal carcinoma
(NPC)2 (2) and that end-binding protein 1 (EB1) is a novel com-
ponent of these activated inflammasome complexes (9). EB1,
which is a plus-end tracking protein (TIP) that regulates
microtubule polymerization by recruiting otherTIPs (10), is
involved in various biological processes, including mitosis,
migration, and signal transduction (10, 11). In our recent
report, we showed that EB1 is critical for speck-like particle
formation byAIM2 inflammasomes following the perception of
double-stranded DNA (9). Furthermore, the perinuclear loca-
tion of the inflammasome speck is known to be crucial for
proper inflammasome activity and IL-1 secretion. However,
the mechanisms underlying EB1-mediated speck formation
and localization have not yet been thoroughly elucidated.
Autophagy is cellular vacuoles that governs cellular homeo-
stasis and responds to cellular stress (12). Mechanistically,
autophagy begins with the nucleation of proautophagic vacu-
oles at the microtubule organizing center (MTOC) (13). The
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autophagic vacuoles then mature; this may be tracked by the
processing of LC3-I to LC3-II via upstream regulators (12). The
mature autophagic vesicles then fuse with lysosomes, enabling
the enzymatic digestion of cellular components. This supports
cellular homeostasis and the clearance of pathogens (12). The
intracellular trafficking of autophagic vacuoles has been shown
to require microtubules (14), suggesting that microtubule
polymerization is important for autophagic movement. Inter-
estingly, autophagy not only prevents cellular damage by clear-
ing proteins and pathogens, it also participates in the uncon-
ventional secretion of certain factors (15, 16). Given that
autophagy can be triggered by ubiquitinated inflammasomes
(17) and the secretion of IL-1 is known to require vesicle shed-
ding (18, 19), we hypothesized that autophagy may be involved
in the secretion of IL-1.
Here, we demonstrate that EB1-activated AIM2 inflam-
masome specks colocalize with MTOCs and are engulfed in
autophagic vacuoles. We show that AIM2 inflammasome-
induced IL-1 secretion depends on autophagy and can be
inhibited by silencing of the autophagic marker, LC3. In
addition, we report that depletion of EB1 decreases
autophagy and IL-1 shedding after AIM2 inflammasome
activation. Finally, we show that 5-AMP-activated protein
kinase (AMPK) may regulate EB1-mediated AIM2 inflam-
masome activation and autophagy-based IL-1 secretion.
Conclusively, we performed the third signal of inflam-
masome-mediated IL-1 secretion via autophagy, which was
elicited by EB1-depended MTOCs location of AIM2 inflam-
masome speck and autophagic shedding.
EXPERIMENTAL PROCEDURES
Antibodies andReagents—The following antibodieswere uti-
lized: anti-caspase 1, anti-EB1 (for immunoprecipitation), anti-
LAMP1 and anti--tubulin (Santa Cruz Biotechnology, Santa
Cruz, CA); anti-FLAG, anti--tubulin, anti-LC3, anti-mouse
IgG (10 nm of colloidal gold) and anti-FLAG M2 affinity gel
(Sigma-Aldrich); anti-ASC (MBL, Woburn, MA); anti-GFP
(GeneTex, Irvine, CA); anti-EB1 (forWestern blot analysis; BD
Transduction Laboratories); anti-AMPK (Epitomic, Burlin-
game, CA); and anti-Thr(P)-172-AMPK (Cell Signaling Tech-
nology, Danvers, MA). The poly(dA-dT), PMA, AICAR, rapa-
mycin, chloroquine, and compound C were purchased from
Sigma-Aldrich. ProteinG Sepharose 4 Fast Flowwas purchased
fromGEHealthcare. Finally, theAmiconUltra 2-ml centrifugal
filters 3K were purchased fromMerck Millipore.
Plasmid Construction—The wild-type EB1 construct was
PCR amplified from HK1 cDNA and cloned into HindIII/
BamHI-treated pFLAG-CMV2 vectors (Clontech). Wild-
type ASC was PCR amplified from HK1 cDNA and cloned
into HindIII/BamHI-treated pEGFP-N1 vectors (Clontech).
Cell Culture—HeLa, NPC TW02, and HK1 cells were cul-
tured as described previously (9), and THP1 cells were cultured
in RPMI medium (9). Lentiviruses were established following
the protocol of the RNAi Core of Taiwan and used to generate
HK1 cells expressing mature human IL-1. The cells were
maintainedwith 500g/mlG418 (Invitrogen). For transfection
assays, cells were transfected with poly(dA-dT) using Lipo-
fectamine 2000 (Invitrogen).
Preparing the Anti-AIM2Antibody—The sequence encoding
the full-length human AIM2 cDNA was cloned into NdeI/
BamHI-treated pET-15b vectors (Novagen). His-AIM2 was
expressed in vector-transformed Rosetta competent cells
treated with 0.5 mM isopropyl -D-1-thiogalactopyranoside for
1.5 h, and the expressed proteins were purified using a nickel
Sepharose High Performance system (GE Healthcare). Two
American Rabbit Breeders Association (New Zealand) rabbits
were immunized twice (interval, 1month) with 1mg of purified
His-AIM2 in Freund’s complete adjuvant. At 10–14 days after
the second (boost) injection, anti-AIM2 sera were obtained
from the immunized rabbits and purified.
Immunoprecipitation—Cells were treated with poly(dA-dT)
for 6 h. Cell extracts (1 mg) were collected using radioimmune
precipitation assay buffer (50mMTris-Cl, pH7.5, 150mMNaCl,
10 mM MgCl2, 1 mM ethylenediamine tetraacetate, pH 8.0, 1%
Nonidet P-40, 100mM sodium fluoride, and 1mM phenylmeth-
ylenesulfonyl fluoride) and immunoprecipitated with specific
antibodies (1 g) or anti-FLAG M2 affinity gel for 24 h. The
antibody-bound samples were precipitatedwith ProteinG Sep-
harose 4 Fast Flow for 1 h at 4 °C, and the immunoprecipitated
products were collected for Western blot analysis.
RNA Interference—Stealth RNAi reagents were purchased
from Invitrogen. These included three 25-bp RNA duplexes for
each of three targets, as follows: AIM2 (5-UAUGGUGCUAU-
GAACUCCAGAUGUC-3; 5-GACAUCUGGAGUUCAUA-
GCACCAUA-3; 5-AAACCAUUCACAAUUGUUCCAA-
GGG-3), EB1 (5-CCGAAGAAACCUCUCACUUCUAGCA-
3; 5-GGAUCAAUGAGUCUCUGCAGUUGAA-3; 5-UCA-
ACGUAUUGAAACUUACUGUUGA-3), LC3 (5-CGGACC-
AUGUCAACAUGAGCGAGUU-3; 5-UCGCGGACAUCU-
ACGAGCAGGAGAA-3; 5-GGCUUCCUCUAUAUGGUC-
UACGCCU-3), and AMPK (5-CCCAUCCUGAAAGAGU-
ACCAUUCUU-3; 5-CCCUCAAUAUUUAAAUCCUUCU-
GUG-3; 5-ACCAUGAUUGAUGAUGAAGCCUUAA-3).
The negative control siRNA was synthesized by Research
Biolabs (Singapore). Cells were transfected with 75 pmol of
dsRNA duplexes using Lipofectamine 2000 according to the
manufacturer’s instructions. After incubation for 6 h, the
dsRNA complexes were removed, and the cells were replated in
5 ml of fresh medium.
IL-1 ELISA—Cell culture supernatants were assayed for
human IL-1 using the human IL-1 ELISA Ready-SET-Go kit
(eBioscience, San Diego, CA) according to the manufacturer’s
instructions.
Western Blot Analysis—Whole-cell extracts were homoge-
nized and lysed in a buffer containing 50 mM Tris-Cl (pH 7.5),
150 mM NaCl, 10 mM MgCl2, 1 mM ethylenediamine tetraac-
etate (pH 8.0), 1%Nonidet P-40, 100mM sodium fluoride, 1mM
phenylmethylenesulfonyl fluoride, and 2 l/ml protease inhib-
itor mixture (Sigma-Aldrich). Protein concentrations were
determined using a protein assay reagent (Bio-Rad), and equal
protein amounts (30–50 g/lane) were resolved by 12% SDS-
PAGE. For the concentrated samples, the culture media were
collected and concentrated with Amicon Ultra 2-ml centrif-
ugal filters. After electrophoresis, the proteins were electro-
transferred onto nitrocellulose membranes (Amersham Bio-
sciences). The blots were blocked with 5% nonfat powdered
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milk in TBS, incubated overnight with the respective primary
antibodies at 4 °C, and then incubated with HRP-conjugated rab-
bit/goat/mouse anti-IgG (Invitrogen) for 1hat roomtemperature.
Protein bands were detected by enhanced chemiluminescence
(Pierce ECL, Thermo Scientific) on Fuji SuperRx films.
Immunofluorescence Microscopy—Cells grown on coverslips
were fixedwith 3.7% formaldehyde, permeabilized, and blocked
overnight at 4 °C with PBS containing 1% BSA. The coverslips
were incubated with the indicated primary antibodies for 2 h
and then with the appropriate fluorophore-conjugated second-
ary antibodies (Invitrogen) for 1 h at room temperature. Nuclei
were stained with 4-6-diamidino-2-phenylindole (Sigma-Al-
drich). All coverslips were mounted with the Vectashield re-
agent (Vector Laboratories) and visualized by confocal micros-
copy (Zeiss LSM510 META laser-scanning microscope; Carl
Zeiss, Germany) with a 63 1.32 or 100 1.32 NA oil immer-
sion objective.
Immunoelectron Microscopy—Cells were fixed in a mixture
of 1% glutaraldehyde and 2%paraformaldehyde in 0.1 M sodium
cacodylate buffer for 2 h and then embedded in 12% gelatin.
FIGURE1.AIM2 inflammasomes localizewithMTOCsand induce IL-1 secretionvia autophagy.A, NPCTW02cellswere transfectedwithGFP-ASC for 48h
and then treatedwith poly(dA-dT) for 6 h. The locations of GFP-ASC, -tubulin, or -tubulin were observed by confocal fluorescencemicroscopy. Scale bar, 20
m. B, NPC TW02 cells were pretreated with TNF for 48 h. Then, NPC TW02 and HK1 cells were treated with rapamycin (30 nM) or chloroquine (50M) for 2 h,
followed by poly(dA-dT) for 12 h. Culture media were collected and subjected to IL-1 ELISA. C, At the indicated time point, HK1 cell extracts were subjected
toWestern blot analysis. *, p 0.05; **, p 0.01.D, HK1 cellswere treatedwith control or LC3-specific siRNA for 48 h and then treatedwith poly(dA-dT) for 12 h.
Culture media and cell extracts were collected for IL-1 ELISA andWestern blot analysis, respectively. Symbols: *, p 0.05; and **, p 0.01. E, NPC TW02 cells
were transfected with Flag-EB1 for 48 h and then treated with poly(dA-dT) for 6 h. Cell extracts were collected for immunoprecipitation with an anti-FLAG
matrix and subjected to Western blot analysis.
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The blocks were trimmed to size, immersed overnight at 4 °C in
PVP/sucrose (15%/1.7 M), mounted on aluminum pins in the
proper orientation, and stored in liquid nitrogen. Frozen sec-
tions were prepared with an ultracryomicrotome (Reichert
Ultracut S/Reichert FCS; Leica, Vienna, Austria). To obtain
ultrathin sections, 0.5-m sections were first cut at 70 °C,
stained with 0.1% Toluidine Blue in 1% boric acid, and exam-
ined under light microscopy. When the cells were reached
within each block, the cutting temperature was lowered to
100 °C, and the section thickness was decreased to 55 nm.
Ultrathin sections were picked up with a drop of an equal vol-
umemixture of methylcellulose (2%)/sucrose (2.3 M). Each sec-
tion was stained with anti-GFP antibodies in 0.1% BSA buffer
for 30 min, followed by anti-IgG gold antibodies for 25 min at
room temperature. The samples were finally mounted with
methylcellulose/uranyl acetate buffer and viewed under a JOEL
JEM-1230 transmission electron microscope.
RESULTS
Activated AIM2 Inflammasomes Colocalize with MTOCs—
Wepreviously reported that EB1 is a component of the NLRP3,
AIM2, and RIG-I inflammasomes in NPC cells and that it is
required for the formation of activated inflammasome specks
(9). To investigate the biological function of EB1 in speck for-
mation, we monitored specks (i.e. activated inflammasomes
(5)) using fluorescence-tagged ASC. Following poly(dA-dT)-
induced AIM2 inflammasome activation, GFP-ASC-labeled
specks showed perinuclear localization (Fig. 1A). Togetherwith
our previous work (9), this finding indicates that AIM2 inflam-
masome specks show EB1-dependent perinuclear localization.
Notably, we observed only one visible inflammasome speck per
poly(dA-dT)-treated cell. Because EB1 regulates microtubule
polymerization at the plus end of themicrotubule (10), we spec-
ulated that EB1 may recruit the AIM2 inflammasome to the
origin of the microtubule or to the MTOC. Immunofluores-
cence microscopy showed that the perinuclear location of the
GFP-ASC specks in poly(dA-dT)-treated cells was specific to
the central cytoskeletal network, as indicated by staining with
anti--tubulin antibodies (Fig. 1A). Because -tubulin is an
essential component of the MTOC, we used anti--tubulin
antibodies to identify the position of the MTOC in our system.
Our results revealed that the GFP-ASC specks in poly(dA-dT)-
treated cells colocalized with the MTOCs (Fig. 1A). Interest-
ingly, this phenomenon has also been observed for NLRP7
inflammasomes (20), suggesting that inflammasome specks
may commonly localize to the MTOC upon activation.
The colocalization of activated inflammasome specks with
the MTOC suggests that the microtubule network may be
involved in inflammasome activation and/or IL-1 secretion.
For the past few decades, researchers have examined cellular
cargo trafficking (21), including the secretion of cytokines or
growth factors. IL-1 secretion has been shown to depend on
vesicular transport (18, 19), and prior reports have shown that
(i) autophagy acts on ubiquitinated inflammasomes (17); (ii) the
intracellular trafficking of autophagosomes depends on the
microtubule network; and (iii) the shedding of these vacuoles
begins at the MTOC (14). Based on our present findings, we
therefore hypothesize that in addition to being required for
speck formation, EB1 also participates in inflammasome acti-
vation/IL-1 secretion by recruiting inflammasomes to the
MTOC and regulating autophagy-dependent secretion.
AIM2 Inflammasome-induced IL-1 Secretion Requires
Autophagy—To examine whether EB1 is involved in the secre-
tion of IL-1, we used NPC cells that stably expressed mature
IL-1 (HK1/mIL1b) and constitutively secreted IL-1 regard-
less of inflammasome stimulation (Fig. 2A) (2). To examine
whether EB1-mediated inflammasome activation was required
for IL-1 secretion, we used the EB1-silenced cells generated in
our previous work (9). Our results revealed that EB1 depletion
reduced the secretion of mature IL-1 from poly(dA-dT)-
treated HK1/mIL1b cells (Fig. 2A), indicating that EB1 is
involved in both inflammasome activation and IL-1 secretion.
To test whether autophagywas also involved in these processes,
we treated two NPC cell lines (HK1 and NPC TW02 cells) with
rapamycin (which induces autophagy by targeting mTOR) or
chloroquine (which inhibits autophagy by blocking the fusion
of the vesicle with the cell membrane) and then subjected the
cells to AIM2 inflammasome activation.We found that chloro-
quine pretreatment significantly decreased IL-1 secretion fol-
FIGURE 2. EB1, autophagy, and AMPK are all involved in IL-1 secretion.
A, HK1/mIL1b cells were pretreated with control siRNA, AIM2 siRNA, or EB1
siRNA for 48 h and then treated with/without poly(dA-dT) for 12 h. Culture
media and cell extracts were subjected to IL-1 ELISA andWestern blot anal-
ysis, respectively. B, HK1/mIL1b cells were treated with control siRNA or LC3
siRNA for 48 h and then treated with/without poly(dA-dT) for 12 h. Culture
media and cell extracts were subjected to IL-1 ELISA andWestern blot anal-
ysis, respectively. C, HK1/mIL1b cells were pretreated with control siRNA or
AMPK siRNA for 48 h and then treated with/without poly(dA-dT) for 12 h.
Culture media and cell extracts were subjected to IL-1 ELISA and Western
blot analysis, respectively.
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lowing poly(dA-dT) treatment in both NPC cell lines, but rapa-
mycin did not have a significant opposite effect (Fig. 1B).
Because the processing of LC3-I to LC3-II reflects the matura-
tion of autophagy (12), we used Western blot analysis to mon-
itor autophagic maturation. We found that poly(dA-dT) treat-
ment increased the levels of LC3-II by 2.2-fold (Fig. 1C; 12 h),
suggesting that the activation of autophagy was subsequent to
that of AIM2 inflammasomes in our system. Notably, HK1 cells
expressed a basal level of LC3-II in the absence of poly(dA-dT)
treatment (Fig. 1C, 0 h). This may explain the low level secre-
tion of IL-1 previously observed from these cells in the
absence of inflammasome stimulation (9), and the less signifi-
cant induction of IL-1 secretion following rapamycin treat-
ment (Fig. 1B). Knockdown of autophagy by silencing of LC3
significantly decreased IL-1 secretion in poly(dA-dT)-treated
HK1 and HK1/mIL1b cells (Figs. 1D and 2B), as well as in a
monocyte cell line (THP1) (Fig. 3A). Immunoprecipitation of
FLAG-EB1 in NPC TW02 cells revealed that the levels of
LC3-II and ASC increased after poly(dA-dT) treatment (Fig.
1E), indicating that mature autophagosomes were associated
with the activated AIM2 inflammasomes. A previous study
showed that the extracellular delivery of IL-1 requires the
autophagy-based secretory pathway (15). Here, we show for the
first time that both EB1 and autophagy are involved in AIM2
inflammasome-induced IL-1 secretion. This is likely to be an
innate and common biological process that occurs in the vari-
ous cell types that undergo inflammasome-associated IL-1
secretion.
GFP-ASC Is Engulfed in Autophagic Vacuoles Following
AIM2 Inflammasome Activation—Because poly(dA-dT) treat-
ment triggers EB1-mediated AIM2 inflammasome speck for-
mation (9), followed by autophagy-dependent IL-1 secretion
in this paper, we next used immunoelectron microscopy to
examinewhetherAIM2 inflammasome speckswere engulfed in
autophagosomes. Consistent with the data from our Western
blot analysis, the microscopic images revealed that poly(dA-
dT) treatment of NPC TW02 cells increased the number of
autophagosomes (Fig. 4,A andC). As indicated by gold particles
coupled to anti-GFP antibodies in GFP-ASC-overexpressing
NPCTW02 cells, the aggregatedGFP-ASCwas engulfedwithin
FIGURE 3. In THP1 cells, EB1 regulates poly(dA-dT)-induced autophagy and AIM2 inflammasome shedding, and AMPK is involved in poly(dA-dT)-
induced IL-1 secretion. A, THP1 cells were pretreated with PMA (2M for 6 h); treated with control siRNA, AIM2 siRNA, EB1 siRNA, or LC3 siRNA for 48 h; and
treated with/without poly(dA-dT) for 4 h. Culture media and cell extracts were subjected to IL-1 ELISA and Western blot analysis, respectively. B, THP1 cells
were pretreatedwith PMA (2M for 6 h), treatedwith control siRNAor AMPK siRNA for 48 h, and then treatedwith/without poly(dA-dT) for 4 h. Culturemedia
and cell extracts were subjected to IL-1 ELISA and Western blot analysis, respectively. **, p 0.01; ***, p 0.001.
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autophagosomes in poly(dA-dT)-treated cells but not in
untreated controls (Fig. 4, B, D, and E). Furthermore, extracel-
lular GFP-ASC was released from the autophagosomes (Fig.
4F). These findings suggest that AIM2 inflammasome com-
plexes and IL-1 enter the secretory pathway via autophagy,
which is required for the inflammasome-mediated secretion of
IL-1.
EB1 Is Required for the Shedding of AIM2 Inflammasomes
and Autophagic Vesicles—To further show that EB1 regulates
IL-1 secretion by eliciting the shedding of inflammasome
complex-containing autophagic vesicles, we investigated the
maturation and shedding of autophagic vesicles in EB1 knock-
down cells. Immunofluorescence analyses revealed that cyto-
solic LC3 puncta (representing activated autophagy) could be
observed in control, AIM2 knockdown, and EB1 knockdown
cells exposed to poly(dA-dT) treatment for 6 h (Fig. 5A). Inter-
estingly, LC3 punctation was reduced at 12 h post-treatment in
control and AIM2 knockdown cells, but not in EB1 knockdown
cells (Fig. 5A). This suggests that EB1 depletion may interfere
with autophagosome trafficking or lead to constitutive activa-
tion of autophagy. Indeed, the levels of LC3-II were 2-fold
higher in culturedmedia from control andAIM2-depleted cells
treatedwith poly(dA-dT) (2.21- and 2.54-fold, respectively) but
not that from the corresponding EB1-depleted cells (0.69-fold)
(Fig. 5B). AIM2 was detected in the culture medium, and
poly(dA-dT) treatment enhanced AIM2 secretion in control
knockdown cells. Importantly, EB1 depletion decreased
poly(dA-dT)-induced autophagy (LC3-II) and AIM2 secretion,
compared with that seen in control siRNA-treated cells (Fig.
5B). Similar results were obtained in THP1 cells: EB1 depletion
affected poly(dA-dT)-induced autophagy and AIM2 inflam-
masome secretion, as monitored by the levels of LC3-II, AIM2,
and caspase 1 in the culture medium, compared with the
knockdown controls (Fig. 3A). Furthermore, LC3 depletion
reduced poly(dA-dT)-induced AIM2 inflammasome secretion
in THP1 cells (Fig. 3A). These results collectively indicate that
AIM2-inflammasome-mediated IL-1 secretion is dependent
on the EB1-directed shedding of autophagosomes.
We also examined whether EB1 regulates the shedding of
autophagic vesicles by altering their intracellular trafficking.
Autophagosomes can fuse with lysosomes to form autolyso-
somes (12), which digest toxic or renewable components. Here,
we used immunofluorescence microscopy to observe the colo-
calization of autophagosomes and lysosomes, which were visu-
FIGURE 4.GFP-ASC localizes to autophagic vacuoles followingAIM2 inflammasomeactivation.A, NPC TW02 cellswere transfectedwithGFP-ASC for 48 h
and then treated with/without poly(dA-dT). Ultrathin sections were stained with gold particles targeting the anti-GFP antibodies and observed by electron
microscopy. Scale bar, 2m. B, imagemagnified from A. Scale bar, 500 nm. C, NPC TW02 cells were transfectedwith GFP-ASC for 48 h, treatedwith poly(dA-dT)
for 4 h, and then examined as described in A. Scale bar, 2 m. D–F, images magnified from C. Scale bar, 500 nm. The arrowhead indicates the gold particles
targeting GFP-ASC. N indicates the nucleus.
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alized with anti-LC3 and anti-LAMP1 antibodies, respectively.
Our results revealed that the colocalization of LC3 and LAMP1
was reduced in poly(dA-dT)-treated NPC and HeLa cells sub-
jected to EB1 knockdown but not in those transfected with
control siRNA (Fig. 6). This suggests that EB1 regulates the
shedding of autophagic vesicles through intracellular traffick-
ing. Collectively, these results indicate that EB1 regulates
inflammasome release by eliciting the shedding of autophagic
vesicles, which is required for the inflammasome-mediated
secretion of inflammasomes and IL-1.
AMPK May Regulate AIM2 Inflammasome Activation by
Targeting EB1—Finally, we sought to identify potential regula-
tors of the EB1-mediated secretions of inflammasomes and
IL-1. AMPK has been reported to control microtubule poly-
merization via the post-translational regulation of microtubule
plus-end proteins (22) and appears to be involved in NLRP1b
inflammasome-derived IL-1 secretion (23). Based on these
previous results, we hypothesized that AMPK may be an
upstream regulator of EB1. To test this possibility, we first pre-
treated cells with theAMPK activator, AICAR (24), or its inhib-
itor, compound C (25), and examined poly(dA-dT)-induced
IL-1 secretion. As shown in Fig. 7A, AMPK phosphorylated at
threonine 172 (Thr(P)-172; which was taken as indicating acti-
vated AMPK) was detected in control cells regardless of
poly(dA-dT) treatment. Cells treatedwith compoundC (5 or 10
mM) showed far less AMPK activation, whereas AICAR had no
significant effect (Fig. 7A). Importantly, pretreatment with
compound C significantly and dose-dependently blocked
poly(dA-dT)-induced IL-1 secretion, whereas this secretion
was potently induced by AICAR (Fig. 7A).
Because AMPK is critical for AMPK kinase activity in the
AMPK protein complex, we tested whether depletion of
AMPK specifically disrupted the function of AMPK. Similar
to the results from our EB1-depletion experiments, AMPK
depletion reduced IL-1 secretion in poly(dA-dT)-treatedHK1
and THP1 cells, whereas control siRNAs had no such effect
(Figs. 3B and 7B). Depletion of AMPK also decreased the
secretion of mature IL-1 from HK1/mIL1b cells (Fig. 2C),
FIGURE5.EB1knockdown reduces autophagyandAIM2shedding.A, NPC TW02 cellswere pretreatedwith control siRNA, AIM2 siRNA, or EB1 siRNA for 48h
and then treated with poly(dA-dT) for the indicated durations. The cells were observed by confocal fluorescence microscopy. Scale bar, 20 m. B, NPC TW02
cells were treated with control siRNA, AIM2 siRNA, or EB1 siRNA for 48 h and then treated with/without poly(dA-dT) for 12 h. Culture media and cell extracts
were subjected to Western blot analysis.
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indicating that AMPK participates in the secretions of inflam-
masomes and IL-1. Co-immunoprecipitation assays with
anti-AMPK antibodies confirmed that EB1 was associated
with AMPK in poly(dA-dT)-treated cells (Fig. 7C). Notably, the
association of EB1 and AMPK occurred at 1 to 3 h after
poly(dA-dT) treatment. This was earlier than the timing of
poly(dA-dT)-induced EB1/AIM2 inflammasome speck forma-
tion (4 to 8 h) (9), suggesting that AMPK may regulate EB1-
mediated AIM2 inflammasome formation and secretion.
Depletion of AMPK abolished the poly(dA-dT)-induced
association of EB1 with AIM2 inflammasomes, as visualized
in an ASC pulldown assay, and reduced the release of
autophagic vesicles and AIM2 to the culture medium (Fig. 7,
D and E). Thus, AMPK may interact with EB1, thereby serv-
FIGURE 6. EB1 knockdown reduces the fusion of autophagic vesicles and lysosomes. A, NPC TW02 cells were pretreated with control siRNA (siC) or EB1
siRNA for 48 h and then treatedwith/without poly(dA-dT) for 6 h. The cells were fixed and stainedwith anti-LC3 and anti-LAMP1 antibodies and then observed
under confocal fluorescence microscopy. B, HeLa cells were prepared and observed as described in A. Scale bar, 20 m.
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ing as an upstream regulator of EB1-mediated inflam-
masome secretion.
Taken together, our findings suggest a model for EB1-medi-
ated, autophagy-dependent AIM2 inflammasome and IL-1
secretion (Fig. 7F). In thismodel, poly(dA-dT) treatment causes
AMPK to associate with EB1 upon AIM2 inflammasome acti-
vation, whereupon EB1 controls the MTOC localization of
AIM2 inflammasome specks, directing them to the autophagic
pathway.
DISCUSSION
EB1 mediates various cellular functions by regulating signal
transduction via alterations in themicrotubule network (11). In
the present study, we identify a novel role for EB1, showing for
the first time that it serves as a platform for AIM2 inflam-
masome recruitment (9) and elicits the autophagy-dependent
secretions of AIM2 inflammasomes and IL-1 (Fig. 7F). Speck
formation has been detected following the activations of mul-
tiple inflammasomes (e.g. the NLRP3, RIG-I, and AIM2 inflam-
masomes (9)) by various stimuli. Our novel finding that EB1
controls the MTOC localization of AIM2 inflammasome
specks may suggest that EB1-mediated inflammasome activa-
tion/autophagy is a common mechanism for inflammasome-
associated IL-1 secretion.
TheMTOC is thought to be the site atwhich autophagosome
precursors are initiated via nucleation (13). This may explain
why speck formation and localization to the MTOC are
required for inflammasome-induced, autophagy-dependent
secretion. Autophagy has been shown to negatively regulate
inflammasome activation by removing oxidative species or
damaged mitochondria (26, 27). Here, we show that autophagy
positively regulates AIM2 inflammasome activation and IL-1
FIGURE 7.AMPKmay regulate EB1. A, HK1 cells were pretreatedwith the indicated doses of compound C or AICAR for 6 h, and then treatedwith poly(dA-dT)
for 12 h. Culture media and cell extracts were subjected to IL-1 ELISA and Western blot analysis, respectively. *, p  0.05; **, p  0.01. B, HK1 cells were
pretreatedwith control siRNAorAMPK siRNA for 48hand then treatedwithpoly(dA-dT) for 12h. Culturemedia andcell extractswere subjected to IL-1ELISA
andWesternblot analysis. *,p 0.05; **,p 0.01.C, NPC TW02 cellswere treatedwith poly(dA-dT) for the indicateddurations, and cell extractswere subjected
to immunoprecipitation.D, NPC TW02 cellswere treatedwith control siRNAorAMPK siRNA for 48h, treatedwithpoly(dA-dT) for 6 h, extracted, and subjected
to immunoprecipitation. E, NPC TW02 cells were treated with control siRNA or AMPK siRNA for 48 h and then treated with/without poly(dA-dT) for 12 h.
Culture media and cell extracts were subjected to Western blot analysis. F, the time course of poly(dA-dT) treatment-induced EB1-mediated AIM2 inflam-
masome delivery via autophagic vacuole shedding, which occurs as follows: 1) AMPK regulates EB1; 2) EB1 regulates the MTOC localization of the AIM2
inflammasome speck; and 3) EB1 elicits AIM2 inflammasome release via autophagic vacuole shedding.
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secretion through vesicular shedding and that these events are
connected via EB1. Thus, autophagy appears to have dual func-
tions with respect to inflammasomes, and future studies are
warranted to investigate the maturation of autophagosomes
before and after inflammasome activation. Caspase 1 activity,
which is involved in the inflammasome-dependent cleavage of
pro-IL-1 to mature IL-1, is reportedly involved in the export
of autophagosomes (28).Notably, we found that thematuration
of autophagosomes was independent of AIM2 inflammasome
activation (Fig. 5A), suggesting that parallel pathways may trig-
ger AIM2 inflammasome activation and autophagy.
The present work also shows for the first time that AMPK
may be a potential regulator upstream of EB1-mediated AIM2
inflammasome activation and release. Although a previous
report suggested that AMPK regulates the maturation of
autophagosomes (29), our results revealed that AMPK deple-
tion did not affect the maturation of autophagosomes but
rather reduced their shedding (Fig. 7E). This suggests that
AMPK may regulate autophagic secretion via EB1-mediated
microtubule regulation. We also found that AMPK associates
with EB1 in poly(dA-dT)-treated cells (Fig. 7C). As EB1 con-
tains potential phosphorylation sites (30), further studies are
warranted to examine whether AMPK regulates EB1 via post-
translationalmodification. The post-translationalmodification
of EB1-associated proteinsmay also be important. Recent stud-
ies have shown that the EB1-EB3 complex regulates microtu-
bule dynamics via phosphorylation of EB3 (31–33). Notably,
phosphopeptides of EB3 were detected by our mass spectro-
metric analysis of AMPK pulldown complexes obtained from
poly(dA-dT)-treated cells (data not shown). Thus, EB-contain-
ing complexes may require AMPK to regulate this activity.
Traditionally, IL-1 secretion is believed to require two sig-
nals: the transcriptional regulation of pro-IL-1 expression,
and the inflammasome-induced, caspase 1-mediated cleavage
of pro-IL-1. Here, we identify a third signal: the autophagy-
mediated secretion of inflammasomes and IL-1 (Fig. 8). Our
study also uncovers an additional role of EB1 as a key compo-
nent that connects inflammasome activity with the autophagy-
based secretory pathway. Notably, the EB1-autophagy pathway
had a stronger effect on IL-1 secretion in NPC cells than in
THP1 cells as suppression of this pathway had more modest
effects on IL-1 release in the monocyte model (Fig. 3A). This
may reflect that additional non-autophagy-based mechanisms,
such as caspase 1-mediated pyroptosis (34), are the critical
pathways for IL-1 secretion in monocytes.
Autophagy is a critical mechanism that protects the host cell
from damage, recycles cellular components, and releases cellu-
lar components (e.g. insulin) via the vesicular secretory path-
way. Thus, autophagy not only functions as a cellular defense
machinery; it also acts as a messenger for synapse-like intercel-
lular communication (21). In new preliminary studies, we have
found that the releases of additional cytokines are also regu-
lated by the autophagy-dependent secretion system inNPC cell
lines following AIM2 inflammasome activation (data not
shown). Future work is therefore warranted to broadly investi-
gate whether other proteins (e.g. cytokines and enzymes) are
FIGURE 8. Model of AIM2 inflammasome-induced IL-1 secretion. Poly(dA-dT)-induced IL-1 secretion depends on a series of signals, including the
following: 1) the transcriptional regulation of IL-1 expression; 2) the EB1-mediated recruitment of the activated inflammasome, which inducesmaturation of
IL-1 via caspase 1; and 3) the EB1-mediated delivery of inflammasome-containing autophagic vesicles.
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also secreted via autophagic vacuoles and to determine how the
autophagic pathway selects its targets for secretion. Interest-
ingly, inflammasome activation is reportedly involved in cellu-
lar senescence and physiological aging (35, 36), and activation
of autophagy has been observed in aging cells (37). Thus, it
would be useful to explore the potential correlation of inflam-
masome activation and autophagy during systemic aging and in
chronic inflammatory diseases. Inflammasome-derived IL-1
secretion participates in various diseases, and this secretion
depends on autophagic delivery. Therefore, inflammasome
activity, autophagic vesicle maturation, and autophagic vesicle
trafficking could all be potential targets for new therapeutic
strategies for treating inflammatory diseases. Autophagy-
dependent inflammasome/IL-1 secretion is an innate
response, and tumoral inflammasome-induced IL-1 secre-
tion is involved in tumor development (2, 38, 39), suggesting
that therapeutic drugs capable of targeting cytoskeletal
polymerizationmay help inhibit autophagic vesicle shedding
and reduce IL-1 secretion. Here, we add to our previous
identification of EB1 in inflammasome complexes by dem-
onstrating a novel pathway in which EB1 elicits a critical step
in inflammasome/IL-1 secretion following inflammasome
activation.
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